This AGXT antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 96-125 amino acids from the Central region of human AGXT.
Optimal dilutions for each application to be determined by the researcher.
Anwendungsbeschreibung:
For IHC-P starting dilution is: 1:25For WB starting dilution is: 1:1000
Antibody staining AGXT in Human hepatic carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
Western Blot at 1:8000 dilution + human liver lysates Lysates/proteins at 20 ug per lane.
Western Blot at 1:2000 dilution + human liver lysates Lysates/proteins at 20 ug per lane.
Western Blot at 1:2000 dilution + human liver lysates Lysates/proteins at 20 ug per lane.
Western Blot at 1:2000 dilution + human liver lysates Lysates/proteins at 20 ug per lane.
Western blot analysis of AGXT Antibody in HepG2 cell line lysates (35ug/lane)(8ug/ml)
AGXT Antibody (RB18848) IHC analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten